Design, synthesis, kinetic, molecular dynamics, and hypoglycemic effect characterization of new and potential selective benzimidazole derivatives as Protein Tyrosine Phosphatase 1B inhibitors-Reference-Cited by-同舟云学术

Design, synthesis, kinetic, molecular dynamics, and hypoglycemic effect characterization of new and potential selective benzimidazole derivatives as Protein Tyrosine Phosphatase 1B inhibitors

Published:2021-10 Issue: Volume:48 Page:116418
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Campos-Almazán Mara Ibeth,Flores-Ramos Miguel^ORCID,Hernández-Campos Alicia,Castillo Rafael,Sierra-Campos Erick,Torgeson Kristiane^ORCID,Peti Wolfgang,Valdez-Solana Mónica,Oria-Hernández Jesús^ORCID,Méndez Sara T.,Castillo-Villanueva Adriana,Jiménez-de Jesús Hugo,Avitia-Domínguez Claudia,Téllez-Valencia Alfredo^ORCID

Funder

Consejo Nacional de Ciencia y Tecnología

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference86 articles.

1. WHO, World Health Organization; 2020 (Accessed November 15th 2020).

2. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Spectrum,2012

3. New oral therapies for type 2 diabetes mellitus: the glitazones or insulin sensitizers;Mudaliar;Annu Rev Med,2001

4. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes;DeFronzo;Diab Rev,1997

5. Non-insulin-dependent diabetes mellitus-a genetically programmed failure of the beta cell to compensate for insulin resistance;Polonsky;N Engl J Med,1996

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on Benzimidazole Heterocyclic Compounds: Synthesis and Their Medicinal Activity Applications;SynOpen;2023-08-17

2. Development of Tyrosine Phosphatase 1B Inhibitors Based on Molecular Docking, Kinetics, and Toxicity Studies;ChemistrySelect;2023-06-14

3. Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders;Bioorganic Chemistry;2022-04